Abstract
ObjectivesTo quantify the carbon footprint from a sample of pharma industry sponsored phase III trials. To develop an approach that can readily be applied to future trials by AstraZeneca and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have